 |
 |
|
TIDES® 2009
寡核酸(oligonucleotide)與胜肽(peptide)相關之技術與製品開發
2009年5月17∼20日
華達州．拉斯維加斯．Red Rock Resort and Spa
|
|
語言選擇
|
|
邀請演講
|
 |
Not Just a Message: Noncoding RNAs in Biology and Medicine
Thomas R. Cech, Ph.D.
Distinguished Professor, University of Colorado-Boulder;
Nobel Laureate, 1989 (Chemistry)
Sponsored by 
|
|
基調講演
 |
Human Genetics and Oligonucleotides: Essential Partners in Pharma's Future
Arthur M. Krieg, M.D.
Chief Scientific Officer, Research Technology Center, Pfizer Inc
|
 |
Peptide Therapeutics: Trends in Global Clinical Development and Approval
Janice M. Reichert, Ph.D.
Senior Research Fellow, Tufts Center for the Study of Drug Development; Editor-in-Chief, mAbs, Landes Bioscience
|
 |
Therapeutic Strategies Using RNA Interference
John J. Rossi, Ph.D
Lidow Family Research Chair, Professor, Division of Molecular Biology; Dean, Graduate School of Biological Sciences; Beckman Research Institute of City of Hope
|
 |
Taking Advantage of Peptide Aggregation
Joel P. Schneider, Ph.D.
Associate Professor, Department of Chemistry and Biochemistry, Department of Materials Science and Engineering, University of Delaware
|
 |
"The TIDES Conference is an invaluable resource to anyone working in the sphere of drug delivery and peptides. The breadth of topics and depth of expertise is extremely impressive."
Gary Riley, D.V.M., Ph.D., Vice-President, Nonclinical Development and Applied Biology, Emisphere Technologies
"This meeting is an assembly of the top investigators in both academics and industry in the field of oligos and peptides."
Joseph Sinkule, Pharm.D., Founder, Director and CSO, Apthera, Inc.
"Excellent summit covering recent progress in oligonucleotide therapeutics."
Anastasia Khvorova, Ph.D., CSO, RXi Pharmaceuticals Corporation
"A unique conference that brings together the many aspects of the Molecular Diagnostics industry."
Nancy Schoenbrunner, Ph.D., Research Leader, Program in Core Research, Roche Molecular Systems, Inc.
- 法規戰略: Lilly、Avecia OligoMedicines、OncoGenex、Ipsen、Millennium及Pfizer之案例學習中，對於了解降低經濟與法規上之風險將有所助益。
- 新技術注目焦點: 寡核酸與胜肽相關2個半天的議程
- 新化學專利的機會與未來的製造市場需求之確認
- 具市場擴大潛力之傳遞技術
- 改善寡核酸與胜肽製品品質與產量之噴霧乾燥
- 以苯并三唑(benzotriazole)為基之偶合劑的非爆炸性替代品
- 改善microRNA標靶之立體塊狀寡核酸及其胜肽結合技術
- 提昇製造效率之固態及液態合成技術
- 錯體分子之分析技術
- 改善特定化與品質管理相關之Merck、Bristol-Myers、華盛頓大學、Regado、Alnylam及Isis的技術戰略與法規戰略
- 涵蓋從傳遞、臨床前期、到臨床開發中，主要候選藥劑最新動向之2個全天的議程
- microRNA、siRNA、LNA、標靶傳遞、SNALP、適性體(aptamers)、1日1回之GLP-1類似物、吸入型肥胖治療用胜肽、PEG替代品、補體抑制劑(complement inhibitors)、pepducin、Ipsen-Roche等與GLP-1analogues、Linaclotide、胜肽co-polymer之合作
New Added Benefits to Attending in 2009!
- 最新投資及合作機會之創新展示
- 面對最緊急課題所進行之未審查策略討論論壇
- 品質保証、RNA製造、生物分析技術相關詳情
- 胜肽與寡核酸管理分析開發及品質管理之訂製課程
|
|
|
TIDES® registration also includes access to IBC's 5th International
Applications of Nucleic Acids Technologies in Molecular Diagnostics
Accelerating Product Development through Cutting Edge Regulatory, Business and Technology Strategies
May 19-20, 2009 · Red Rock Casino, Resort & Spa · Las Vegas, NV
Keynote Presentations
 |
|
Molecular Diagnostics: Revolution, Regulation and Reimbursement
Alberto Gutierrez, Ph.D.
Deputy Director, New Product Evaluation, Office of In Vitro Diagnostic Device Evaluation and Safety
CDRH, US FDA
|
|
 |
|
Molecular Diagnostics: A Key Component of the Future Healthcare Value Chain
George Poste, D.V.M., Ph.D.
Director, The Biodesign Institute
Arizona State University
|
|
 |
|
Reagent Solutions to Challenges in Oligonucleotide Diagnostics
Steven A. Benner, Ph.D.
Distinguished Fellow
Foundation for Applied Molecular Evolution Inc.
|
|
|
